胰腺癌中的循环RNA:生物发生,机制,功能和临床应用
Hang Chen1, Xianxing Wang1, Shan Liu2
1Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China.
International journal of medical sciences
|March 17, 2025
概括
循环RNAs (circRNAs) 在胰腺癌 (PC) 的发展中起着关键作用. 本综述详细介绍了它们的生物发生,功能和作为生物标志物和PC的治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 在瘤学瘤学.
背景情况:
- 循环RNA (circRNAs) 是一种高度保守的,性闭合的RNA分子,存在于真核生物中.
- circRNAs表现出组织和细胞特异性表达,表明其作为诊断和预后生物标志物的潜力.
- 它们通过多种分子机制在胰腺癌 (PC) 进展中发挥关键作用.
研究的目的:
- 系统地审查 circRNAs 在胰腺癌中的生物发生,功能,分子机制和临床应用.
- 突出circRNAs作为PC诊断和预后生物标志物的潜力.
- 讨论circRNAs作为胰腺癌的治疗点.
主要方法:
- 关于胰腺癌中circRNAs最近研究的文献综述.
- 关于circRNA生物发生和功能机制的系统概述.
- 对circRNAs在PC发生和进展中的作用的分析.
主要成果:
- 循环RNAs作为miRNA海绵,RBP海绵,转录调节器,分子支架和翻译模板.
- circRNAs与胰腺癌的发生和进展有关.
- circRNAs显示为PC诊断和预后的生物标志物具有前途.
结论:
- 了解circRNA生物发生和功能对于推进胰腺癌研究至关重要.
- 解决circRNA检测方面的技术挑战将促进临床应用.
- circRNAs代表了胰腺癌的有希望的生物标志物和治疗点.
相关概念视频
02:57piRNA - Piwi-interacting RNAs
6.7K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.7K
02:55The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
01:22MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K